Bergisch-Gladbach, Germany

Gunter Schollnhammer


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1983-1989

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Gunter Schollnhammer: Innovator in Antidepressant Compounds

Introduction

Gunter Schollnhammer is a notable inventor based in Bergisch-Gladbach, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that have potential applications as antidepressants. With a total of 2 patents, his work is recognized for its innovative approach to addressing mental health issues.

Latest Patents

Schollnhammer's latest patents focus on the provision of 7,8,9,10-tetrahydrothieno[3,2-e]pyrido[4,3-b]indoles. These compounds are useful as antidepressants and serve as intermediates for their preparation. The inventions include compositions containing these indoles and methods for their use as antidepressants. Additionally, he has developed new compounds within this class that influence the central nervous system, marking a significant advancement in the field.

Career Highlights

Gunter Schollnhammer is associated with Troponwerke GmbH & Co. KG, where he has been instrumental in research and development. His work has contributed to the understanding and potential treatment of mental health disorders through innovative chemical compounds.

Collaborations

Some of his notable coworkers include Peter-Rudolf Seidel and Karl-Heinz Boltze. Their collaborative efforts have further enhanced the research and development of new therapeutic agents.

Conclusion

Gunter Schollnhammer's contributions to the field of medicinal chemistry, particularly in the development of antidepressant compounds, highlight his innovative spirit and dedication to improving mental health treatments. His work continues to inspire advancements in this critical area of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…